Evidence map›Paper›PMID 29514691›Full record

ReviewBMC systems biology2018

Systems biology as an emerging paradigm in transfusion medicine.

James T Yurkovich, Aarash Bordbar, Ólafur E Sigurjónsson, Bernhard O Palsson

Abstract readReview
In one paragraph

Review in BMC systems biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Red Blood Cell Omics and Machine Learning in Transfusion Medicine: Singularity Is Near.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  3. Benford's law and metabolomics: A tale of numbers and blood.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020
    Review
  4. Transfusion medicine: Overtime paradigm changes and emerging paradoxes.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2020
    Article
  5. Article
  6. Article
  7. Red blood cell storage lesion: causes and potential clinical consequences.Blood transfusion = Trasfusione del sangue · 2019
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

James T YurkovichDepartment Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, 92093, USA.
Aarash BordbarSinopia Biosciences, 600 W Broadway Suite 700, San Diego, 92101, USA.
Ólafur E SigurjónssonSchool of Science and Engineering, Reykjavík University, Hringbraut 101, Reykjavík, 101, Iceland.
Bernhard O PalssonDepartment Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, 92093, USA. palsson@ucsd.edu.ORCID 0000-0002-9403-509X

Funding

Improving red blood cell transfusion through systems biologyR43HL123074 · NHLBI · SINOPIA BIOSCIENCES, INC. · PI BORDBAR, AARASH · 2014 to 2014
$150k
NHLBI NIH HHS R43 HL123074
6 · The paper itself

Abstract

Blood transfusions are an important part of modern medicine, delivering approximately 85 million blood units to patients annually. Recently, the field of transfusion medicine has started to benefit from the "omic" data revolution and corresponding systems biology analytics. The red blood cell is the simplest human cell, making it an accessible starting point for the application of systems biology approaches.In this review, we discuss how the use of systems biology has led to significant contributions in transfusion medicine, including the identification of three distinct metabolic states that define the baseline decay process of red blood cells during storage. We then describe how a series of perturbations to the standard storage conditions characterized the underlying metabolic phenotypes. Finally, we show how the analysis of high-dimensional data led to the identification of predictive biomarkers.The transfusion medicine community is in the early stages of a paradigm shift, moving away from the measurement of a handful of chosen variables to embracing systems biology and a cell-scale point of view.

Indexed as

ErythrocytesHumansMultivariate AnalysisSystems BiologyTransfusion MedicineMetabolismRed blood cellStorage lesionSystems biologyTransfusion medicine

Identifiers

PMID29514691
PMCPMC5842607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.